The global minimally invasive surgery devices market was valued at USD 19.07 billion in 2024 and is projected to grow to USD 20.27 billion in 2025, reaching USD 34.93 billion by 2032. This reflects a compound annual growth rate (CAGR) of 8.1% during the forecast period. In 2024, North America led the market, accounting for a dominant share of 40.27%.
The minimally invasive surgery devices market is expanding rapidly due to rising demand for precision-driven, low-risk surgical procedures. Key segments such as endoscopic and robotic-assisted devices are gaining prominence owing to technological advancements and growing adoption in complex surgeries. Applications in orthopedics, cardiology, and gynecology are driving market growth, supported by the increasing incidence of chronic conditions and sports injuries. Hospitals and ambulatory surgical centers remain the primary end-users due to access to advanced infrastructure, while specialty clinics and training institutions are contributing to broader adoption across regions.
Continue reading for more details:
https://www.fortunebusinessinsights.com/minimally-invasive-surgery-devices-market-113274
Market Segmentation
- By Type: Endoscopic devices lead the market due to rising endovascular surgeries, followed by inflation and guiding devices offering enhanced precision. Robotic-assisted surgery devices are expected to grow fastest due to technological collaborations and demonstrations.
- By Application: Orthopedic applications dominate owing to the surge in fractures and joint surgeries, while cardiology and gastrointestinal segments follow. Gynecology and neurology segments are projected to grow rapidly due to rising patient volumes and disease prevalence.
- By End-User: Hospitals & ASCs dominate the market due to higher surgical volumes and robotic surgery initiatives, while clinics grow steadily with increased specialization. Other facilities like academic clinics and military hospitals contribute to adoption through training and emergency care.
List Of Key Minimally Invasive Surgery Devices Companies Profiled:
- Medtronic (Ireland)
- Johnson & Johnson Services, Inc. (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Boston Scientific Corporation (U.S.)
- Olympus Corporation (Japan)
- Stryker (U.S.)
- Braun SE (Germany)
- Steris (U.S.)
- Intuitive Surgical (U.S.)
Market Growth
- The minimally invasive surgery devices market is witnessing robust growth due to rising demand for faster recovery times and reduced surgical risks.
- Increasing adoption of advanced technologies such as robotics, 3D visualization, and energy-based devices is significantly driving the minimally invasive surgery devices market.
- Surge in geriatric population and prevalence of chronic diseases are contributing to the rising demand for minimally invasive procedures globally.
- Continuous innovations and product launches are supporting the expansion of the minimally invasive surgery devices market.
- Patient preference for minimally invasive techniques over traditional open surgeries is fueling market growth across healthcare systems.
Restraining Factors
- High cost of minimally invasive surgery devices and robotic surgical systems remains a significant barrier to widespread adoption.
- Lack of skilled professionals and adequate training for advanced minimally invasive procedures can limit market growth.
- Stringent regulatory pathways and lengthy product approval timelines may hinder the timely introduction of new devices into the minimally invasive surgery devices market.
- Limited access in rural and low-resource settings poses a challenge for market penetration.
- Concerns about device malfunctions and safety in certain high-risk procedures may also restrict growth in the minimally invasive surgery devices market.
Regional Analysis
- North America dominates the minimally invasive surgery devices market due to advanced healthcare infrastructure, strong R&D capabilities, and early adoption of new technologies.
- Europe holds a significant share in the market, supported by increasing awareness and favorable reimbursement policies.
- Asia Pacific is emerging as a high-growth region in the minimally invasive surgery devices market, driven by improving healthcare access and rising medical tourism.
- Latin America is showing steady progress, particularly in urban centers with increasing investment in surgical technology.
- The Middle East & Africa region is witnessing gradual adoption of minimally invasive surgery devices, with market growth supported by rising healthcare investments and government initiatives.
Key Industry Developments
- April 2025: Medtronic expanded the URO clinical trial, the largest of its kind for robotic-assisted urologic surgery, and demonstrated excellent safety and effectiveness.
- March 2024: Intuitive Surgical received FDA 510(k) clearance for da Vinci 5, the company’s next-generation multiport robotic system, to offer a smooth experience in minimally invasive surgery.